Endo Tools Therapeutics has closed a $23.0M Series C round, a fresh infusion of capital for the Belgian medical device developer. The company, known for building therapeutic tools that give endoscopists new ways to intervene during procedures, is positioning itself as a quiet but steady player in the shift toward less invasive care.
The funding arrives as ETT looks to push its pipeline forward, though the company has not disclosed who participated in the round or what specific milestones the cash will target. What’s clear is the bet: that its devices, designed to support physicians with cutting-edge options, can carve out a niche in a field where precision and patient outcomes are the real currency.


















